A risk grouping algorithm for predicting factors of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.

Journal: International journal of clinical practice
Published Date: Jun 22, 2021

Abstract

OBJECTIVE: After radical prostatectomy, prostate-specific antigen(PSA) value measuring ≥0.1 ng/mL is defined as persistent PSA(pPSA) and in many studies, it was found to be associated with aggressive disease and poor prognosis. Our aim in this study is to point out the pathological and clinical factors affecting pPSA among the patients who underwent robot-assisted radical prostatectomy(RARP) in an experienced academic centre and to make a useful risk grouping algorithm that can predict pPSA value based on operative data.

Authors

  • Uygar Micoogullari
    Department of Urology, Tepecik Education and Research Hospital, University of Health Sciences, İzmir, Turkey.
  • Mehmet Caglar Cakici
    Department of Urology, School of Medicine, Istanbul Medeniyet University, İstanbul, Turkey.
  • Erdem Kisa
    Department of Urology, Tepecik Education and Research Hospital, University of Health Sciences, İzmir, Turkey.
  • Abdullah Erdem Canda
    School of Medicine, Yildirim Beyazit University, Ankara Ataturk Research & Training Hospital, Ankara, Turkey. Electronic address: erdemcanda@yahoo.com.
  • Furkan Umut Kilic
    Department of Urology, School of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey.
  • Arslan Ardicoglu
    Department of Urology, School of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey.
  • Serkan Altinova
    Department of Urology, Medicana Hospital, Ankara, Turkey.
  • Ali Fuat Atmaca
    Deparment of Urology, Memorial Hospital Ankara, Ankara, Turkey.
  • Ziya Akbulut
    Department of Urology, Liv Hospital, Ankara, Turkey.
  • Mevlana Derya Balbay
    Department of Urology, School of Medicine, Koç University, Istanbul, Turkey.

Keywords

External Resources

Popular Topics
Recent Journals